USA legislation

Generic biologics legislation

UAEM is working with Anthony So (Duke), UCGH, AMSA, and Essential Action to address serious concerns with legislation being proposed in the USA on patent protection for biologic drugs, especially in terms of the number of years of exclusivity, and the problem of evergreening.

Read more: www.AffordableMedsNow.org

Bill S4040

Senator Leahy (VT) proposed the Public Research in the Public Interest Act of 2006 (S.4040) to ensure that innovations developed at federally-funded institutions (such as universities) are made available in certain developing countries at the lowest possible cost. The bill did not pass.

For further information:

• Public Research in the Public Interest (S.4040)
• S4040 Backgrounder